EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY-NC 4.0

Impact of cognitive behavioural therapy on neural, inflammatory, & autonomic markers in a sample with PTSD and cardiovascular risk: protocol for a pilot randomised controlled trial

Robyn Ellis iD, Sinead Sinnott, Krystel Karam, Alula Assefa, Michael Osborne, Antonia Seligowski

European Journal of Psychotraumatology · 2024

DOI: 10.1080/20008066.2024.2378618 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Psychotraumatology, 2024. Verfasst von Robyn Ellis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cognitive Behavioral Therapy, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with posttraumatic stress disorder (PTSD) are at heightened risk for cardiovascular disease (CVD) compared to the general population. Inflammation and autonomic dysfunction are candidate mechanisms of CVD risk in PTSD; however, these mechanisms have not been well-characterised in the PTSD-CVD link. Further, these mechanisms may operate through altered stress-related neural activity (SNA). Yet, it remains unknown if changes in PTSD are associated with changes in CVD risk mechanisms.

Objective

This manuscript describes the design and procedures of a pilot randomised controlled trial to assess the impact of a first-line treatment for PTSD (Cognitive Processing Therapy; CPT) versus waitlist control on mechanisms of CVD risk. Further, this study will test the hypothesis that CPT reduces CVD risk through its effects on inflammation and autonomic function and that these changes are driven by changes in SNA.

Methods

Adults with PTSD and CVD risk (N = 30) will be randomised to CPT or waitlist control. Participants complete two laboratory visits (baseline and post-treatment) that include surveys, brain and peripheral imaging via 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and resting measures of autonomic function. Primary outcomes include arterial inflammation and heart rate variability. Secondary outcomes include leukopoiesis (bone marrow uptake), heart rate, and blood pressure. The indirect effects of PTSD treatment on changes in inflammation and autonomic function through SNA will also be examined.

Conclusions

This study seeks to characterise candidate neuroimmune mechanisms of the PTSD-CVD link to identify treatment targets and develop personalised interventions to reduce CVD events in PTSD populations.

Trial registration

ClinicalTrials.gov identifier: NCT06429293.. Individuals with posttraumatic stress disorder (PTSD) have greater risk for cardiovascular disease (CVD) than the general population.Autonomic dysfunction and inflammation are candidate mechanisms of the PTSD-CVD link, which may be driven by changes in neural activity.This pilot randomised controlled trial will test the impact of a first-line PTSD treatment on autonomic dysfunction and inflammation, and whether neural alterations are associated with changes in these mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCognitive Behavioral TherapyStress Disorders, Post-TraumaticAdultFemaleHumansMaleMiddle AgedAutonomic Nervous SystemBiomarkersInflammationPilot ProjectsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

CVDECVPTSDTEPTactividad autonómicaactividad neuronal relacionada con el estrésautonomic functioninflamacióninflammationstress-related neural activity

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • McLean Hospital, Belmont, MA, USA.
  • Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

ORCID-Profile: Robyn Ellis

Förderung

  • NHLBI NIH HHS
  • American Heart Association-American Stroke Association
  • American Heart Association

Zitieren

APA

Ellis, R., Sinnott, S., Karam, K., Assefa, A., Osborne, M., & Seligowski, A. (2024). Impact of cognitive behavioural therapy on neural, inflammatory, & autonomic markers in a sample with PTSD and cardiovascular risk: protocol for a pilot randomised controlled trial. European Journal of Psychotraumatology. https://doi.org/10.1080/20008066.2024.2378618

Vancouver

Ellis R, Sinnott S, Karam K, Assefa A, Osborne M, Seligowski A. Impact of cognitive behavioural therapy on neural, inflammatory, & autonomic markers in a sample with PTSD and cardiovascular risk: protocol for a pilot randomised controlled trial. European Journal of Psychotraumatology. 2024. doi:10.1080/20008066.2024.2378618

BibTeX
@article{Ellis2024,
  author = {Ellis, Robyn and Sinnott, Sinead and Karam, Krystel and Assefa, Alula and Osborne, Michael and Seligowski, Antonia},
  title = {Impact of cognitive behavioural therapy on neural, inflammatory, & autonomic markers in a sample with PTSD and cardiovascular risk: protocol for a pilot randomised controlled trial},
  journal = {European Journal of Psychotraumatology},
  year = {2024},
  doi = {10.1080/20008066.2024.2378618}
}
Kostenlos starten →